Although the pro-angiogenic effect of CD11b+CX3CR1+ monocytes has not been well described in human cancer types, these findings suggest that CD11b+CX3CR1+ monocytes might promote tumor growth and progression by enhancing angiogenesis in DLBCL. Here, CX3CR1 is linked to neoplasm.